Search

Your search keyword '"Berg, Thomas"' showing total 4,317 results

Search Constraints

Start Over You searched for: Author "Berg, Thomas" Remove constraint Author: "Berg, Thomas"
4,317 results on '"Berg, Thomas"'

Search Results

9. RELIGIOUS LIBERTY APOLOGETICS

12. Basal MET phosphorylation is an indicator of hepatocyte dysregulation in liver disease

18. A global initiative for ecological and evolutionary hologenomics

19. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

23. Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

24. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease

27. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B

28. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

29. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

31. Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma

34. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

35. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022

36. A global research priority agenda to advance public health responses to fatty liver disease

37. Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progression

38. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study

39. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

40. Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency

41. A new machine-learning-based prediction of survival in patients with end-stage liver disease

42. Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial

43. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

44. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients

46. Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib

48. Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial

49. Leber

50. Adressen

Catalog

Books, media, physical & digital resources